240 related articles for article (PubMed ID: 3541135)
21. Emergence of resistance in gram-negative bacteria: a risk of broad-spectrum beta-lactam use.
Dworzack DL
Drug Intell Clin Pharm; 1986; 20(7-8):562-7. PubMed ID: 3488894
[TBL] [Abstract][Full Text] [Related]
22. Genetic and biochemical basis of resistance of Enterobacteriaceae to beta-lactam antibiotics.
Wiedemann B
J Antimicrob Chemother; 1986 Oct; 18 Suppl B():31-8. PubMed ID: 3491818
[TBL] [Abstract][Full Text] [Related]
23. [Penicillin--binding protein: the target for beta-lactam antibiotics, beta-lactamases and their inhibitors].
Lessel J
Pharm Unserer Zeit; 1996 Jan; 25(1):17-27. PubMed ID: 8882750
[No Abstract] [Full Text] [Related]
24. Role of permeability barriers in resistance to beta-lactam antibiotics.
Nikaido H
Pharmacol Ther; 1985; 27(2):197-231. PubMed ID: 2412244
[No Abstract] [Full Text] [Related]
25. Mechanisms of resistance of enterococci to beta-lactam antibiotics.
Fontana R; Canepari P; Lleò MM; Satta G
Eur J Clin Microbiol Infect Dis; 1990 Feb; 9(2):103-5. PubMed ID: 2180705
[TBL] [Abstract][Full Text] [Related]
26. Antibacterial properties of the bicyclic pyrazolidinones.
Allen NE; Hobbs JN; Preston DA; Turner JR; Wu CY
J Antibiot (Tokyo); 1990 Jan; 43(1):92-9. PubMed ID: 1689710
[TBL] [Abstract][Full Text] [Related]
27. Ways to overcome cephalosporinase-mediated beta-lactam resistance in Enterobacter cloacae.
Then RL; Angehrn P
Chemioterapia; 1985 Feb; 4(1):83-9. PubMed ID: 3872727
[TBL] [Abstract][Full Text] [Related]
28. Penicillin-binding proteins of Pseudomonas aeruginosa. Comparison of two strains differing in their resistance to beta-lactam antibiotics.
Curtis NA; Orr D; Boulton MG; Ross GW
J Antimicrob Chemother; 1981 Feb; 7(2):127-36. PubMed ID: 6783607
[No Abstract] [Full Text] [Related]
29. Modification of penicillin-binding proteins as mechanisms of beta-lactam resistance.
Malouin F; Bryan LE
Antimicrob Agents Chemother; 1986 Jul; 30(1):1-5. PubMed ID: 3530121
[No Abstract] [Full Text] [Related]
30. Emergence of resistance during beta-lactam therapy of gram-negative infections. Bacterial mechanisms and medical responses.
Pechère JC
Drugs; 1988; 35 Suppl 2():22-8. PubMed ID: 3260854
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms responsible for reduced susceptibility to imipenem in Bacteroides fragilis.
Edwards R; Greenwood D
J Antimicrob Chemother; 1996 Dec; 38(6):941-51. PubMed ID: 9023641
[TBL] [Abstract][Full Text] [Related]
32. Susceptibility of anaerobic bacteria to Sch 34343 and other beta-lactam antibiotics.
Jacobus NV; Tally FP; Gorbach SL
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():189-91. PubMed ID: 4030547
[TBL] [Abstract][Full Text] [Related]
33. State of penicillin-binding proteins and requirements for their bactericidal interaction with beta-lactam antibiotics in Serratia marcescens highly resistant to extended-spectrum beta-lactams.
Gunkel AG; Hechler U; Martin HH
J Gen Microbiol; 1991 Feb; 137(2):243-52. PubMed ID: 2016583
[TBL] [Abstract][Full Text] [Related]
34. In vitro activity of CGP 31608, a new penem.
Wise R; Andrews JM; Piddock LJ
Antimicrob Agents Chemother; 1987 Feb; 31(2):267-73. PubMed ID: 3105451
[TBL] [Abstract][Full Text] [Related]
35. Penicillin binding proteins, beta-lactams, and lactamases: offensives, attacks, and defensive countermeasures.
Koch AL
Crit Rev Microbiol; 2000; 26(4):205-20. PubMed ID: 11192022
[TBL] [Abstract][Full Text] [Related]
36. Penicillin-binding proteins and the future of beta-lactam antibiotics. The Seventh Fleming Lecture.
Spratt BG
J Gen Microbiol; 1983 May; 129(5):1247-60. PubMed ID: 6352855
[No Abstract] [Full Text] [Related]
37. Synergism and antagonism in double beta-lactam antibiotic combinations.
Gutmann L; Williamson R; Kitzis MD; Acar JF
Am J Med; 1986 May; 80(5C):21-9. PubMed ID: 3487247
[TBL] [Abstract][Full Text] [Related]
38. Emergence of resistance to beta-lactam antibiotics in Pseudomonas aeruginosa during treatment with new beta-lactams.
Lerner SA; Quinn JP
Chemioterapia; 1985 Feb; 4(1):95-101. PubMed ID: 3921267
[TBL] [Abstract][Full Text] [Related]
39. Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillin-binding proteins, and stability to hydrolysis by beta-lactamases.
Yang Y; Bhachech N; Bush K
J Antimicrob Chemother; 1995 Jan; 35(1):75-84. PubMed ID: 7768785
[TBL] [Abstract][Full Text] [Related]
40. In vitro antibacterial activity and interactions with beta-lactamases and penicillin-binding proteins of the new monocarbam antibiotic U-78608.
Zurenko GE; Truesdell SE; Yagi BH; Mourey RJ; Laborde AL
Antimicrob Agents Chemother; 1990 May; 34(5):884-8. PubMed ID: 2193625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
